Regeneron Pharmaceuticals
REGN
#117
Rank
S$165.94 B
Marketcap
$1,505
Share price
0.20%
Change (1 day)
34.08%
Change (1 year)

Regeneron Pharmaceuticals (REGN) - Total liabilities

Total liabilities on the balance sheet as of June 2024 : S$10.26 B

According to Regeneron Pharmaceuticals's latest financial reports the company's total liabilities are S$10.26 B. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Regeneron Pharmaceuticals - Total liabilities on balance sheet (from 2001 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31S$9.38 B6.89%
2022-12-31S$8.78 B-2.32%
2021-12-31S$8.98 B10.78%
2020-12-31S$8.11 B62.42%
2019-12-31S$4.99 B23.19%
2018-12-31S$4.05 B15.73%
2017-12-31S$3.50 B-4.07%
2016-12-31S$3.65 B32.04%
2015-12-31S$2.76 B62.66%
2014-12-31S$1.70 B34.38%
2013-12-31S$1.26 B23.87%
2012-12-31S$1.02 B-5.82%
2011-12-31S$1.08 B49.92%
2010-12-31S$0.72 B49.52%
2009-12-31S$0.48 B11.2%
2008-12-31S$0.43 B-36.75%
2007-12-31S$0.68 B21.81%
2006-12-31S$0.56 B9.64%
2005-12-31S$0.51 B20.27%
2004-12-31S$0.42 B-26.37%
2003-12-31S$0.58 B36.56%
2002-12-31S$0.42 B0.5%
2001-12-31S$0.42 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
S$110.69 B 978.31%๐Ÿ‡บ๐Ÿ‡ธ USA
S$5.22 B-49.08%๐Ÿ‡บ๐Ÿ‡ธ USA
S$14.21 B 38.50%๐Ÿ‡บ๐Ÿ‡ธ USA
S$142.69 B 1,290.05%๐Ÿ‡บ๐Ÿ‡ธ USA
S$72.42 B 605.53%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
S$79.25 B 672.03%๐Ÿ‡ซ๐Ÿ‡ท France